Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q3 EPS of ($0.70), $0.18 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.